Equity Long-Short

Mo Aziz

Capital markets veteran with 25 years across sell-side and buy-side research, investor relations, and fund management. Currently publish independent equity research (Mofferies Investment Research, via Smartkarma) spanning semiconductor memory (DRAM/NAND/HBM), foundry, semiconductor equipment and advanced packaging, gold and cross-asset strategy, financials forensics, and APAC IPOs — with a standing watchlist of 190+ companies across 41 countries. Background includes deep aviation-sector expertise (airlines, airports, OEMs, lessors, air cargo, travel/OTAs). Approach centers on identifying cyclical inflection points and mispriced risk across sectors, translated into explicit, actionable calls.

SK Hynix (000660 KS | SKHY US): Nosebleed Monday, Not a Bloodbath — Fundamentals Say Stay Bullish

SK Hynix (000660KS, SKHY US) — 29 July Judgment Day: Q2 Preview and the Premium's Date with Gravity

SK Hynix (000660 KS): Investors Buy Leveraged ETFs Into Sharp Selloff

SK Hynix Inc. (000660 KS / SKHY US) — Initiation

SK Hynix ADR: The TSMC Analogy Is Intellectually Lazy — Here Is What Actually Matters

SK Hynix (000660 KS): Buy the Supercycle's Crown Jewel

Equity Bottom-Up

<ul>
<li>Priced at US$149/ADR, raising US$26.5bn — the largest-ever US first-time share sale by a foreign company. Order book approached US$200bn. Access thesis emphatically validated.</li>
<li>KRX fell ~15% during the roadshow on memory-sector unwind — our buy-the-dip window arrived early. <strong>BUY reiterated: KRX TP ₩3.5mn unchanged; ADR TP ~US$230,</strong> +54% from pricing.</li>
<li>Fungibility is now the live trade: UBS is pushing long-ADR/short-KRX citing conversion restrictions. The Form F-6 read — our flagged Risk #4 — decides the premium path.</li>
</ul>


Priced at US$149/ADR, raising US$26.5bn — the largest-ever US first-time share sale by a foreign company. Order book approached US$200bn. Access thesis emphatically validated.
KRX fell ~15% during the roadshow on memory-sector unwind — our buy-the-dip window arrived early. BUY reiterated: KRX TP ₩3.5mn unchanged; ADR TP ~US$230, +54% from pricing.
Fungibility is now the live trade: UBS is pushing long-ADR/short-KRX citing conversion restrictions. The Form F-6 read — our flagged Risk #4 — decides the premium path.


SK Hynix ADR: US$200bn Book, US$26.5bn Raised — Marking Our Calls to Market on Debut Day